Top Markets
Coin of the day
Synmosa Biopharma Corporation Synmosa Biopharma Corporation

Synmosa Biopharma Corporation

4114
株式のランク #13203
Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates... Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates as a dedicated specialty pharmaceutical enterprise. The company manages the entire lifecycle of pharmaceutical and healthcare products, from research and development to manufacturing, marketing, and distribution, primarily serving the Taiwanese market under its proprietary Synmosa brand. Its diverse product portfolio addresses key therapeutic categories, including cardiovascular health, respiratory conditions, urology, sex hormone treatments, and oncology. These offerings are available in various formats such as effervescent tablets, granules, nasal sprays, metered-dose inhalers, hormonal preparations, and other specialized forms. Beyond its proprietary products, Synmosa also extends its expertise through contract manufacturing services. The company maintains a significant international presence, exporting its goods to numerous countries including South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua.
株価
$0.94761103
時価総額
$511.40M
変化(1日)
-0.33%
変化(1年)
-9.95%
TW
取引 Synmosa Biopharma Corporation (4114)

カテゴリー

Synmosa Biopharma Corporation(4114)の利益
2026 時点の利益 TTM: 0
Synmosa Biopharma Corporation の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Synmosa Biopharma Corporation の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。